The prevalence of ALT in gliomas (studies with mixed oligodendroglial and astrocytic tumors or unspecified gliomas) ranges from 13 to 69% (Table 2) [40,81,82,83,84,85,86,87,88,89,90,91]. The gene discussed is GPT; the disease is central nervous system cancer.